Drug Trial Snapshot: DAURISMO

DAURISMO is used to treat adults with newly-diagnosed acute myeloid leukemia (AML). It is to be used in patients who•are 75 years of age or older, or•have other medical conditions that prevent the use of standard chemotherapy. AML is a rapidly progressing cancer that forms in the bone marrow and
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news